Report Categories
View AllRecent Articles
View All
HAE Haemonetics Corporation reports Q1 2026 EPS beat as shares rise 243 percent on 4 percent year over year revenue growth
Is Enova International ENVA stock overpriced relative to performance Q4 2025 Profit Exceeds Views
Immunovant IMVT Innovation Pipeline Immunovant posts 163 EPS beat on narrower loss
Zepp ZEPP Stock Gap Down Watch Smart Money Flows 20260418